Small intestinal bacterial overgrowth (SIBO) is still labeled a "GI diagnosis," but your SIBO patients live in endocrine, allergy, rheumatology, and primary care clinics as well as yours.
This first article in the Beyond the Gut series is written for you as a gastroenterologist. The goal is simple: show how hypothyroidism links to SIBO, why that matters for your workups, and why a coordinated approach with endocrinology makes sense.
The short answer
Hypothyroidism raises SIBO risk through two mechanisms you already understand: slowed gastric emptying and small bowel transit, and the broader immune activation that comes with autoimmune thyroid disease. Cedars-Sinai investigators found higher SIBO risk in hypothyroid patients than in euthyroid controls, higher still with autoimmune thyroid disease, and lower risk among patients treated with levothyroxine. The practical implication: thyroid status belongs in your pretest probability, and recurrent SIBO in a poorly controlled hypothyroid patient is a shared problem with endocrinology rather than a GI treatment failure.
What recent data show
Cedars-Sinai investigators reported in the Journal of Clinical Endocrinology & Metabolism that:
- Patients with hypothyroidism had a higher risk of SIBO than euthyroid controls.
- Risk was higher with autoimmune thyroid disease.
- Treated patients on levothyroxine had lower SIBO risk than untreated patients.
Direction of risk
How SIBO risk moves with thyroid status
Reference group
Lower risk than untreated hypothyroid patients
Elevated versus euthyroid controls
Highest risk in the reported gradient
The signal is consistent with what many GIs already see in clinic: a subset of hypothyroid patients with "IBS" symptoms, recurrent bloating, or treatment-resistant SIBO.
Why this makes sense for you
Three points matter for GI practice.
Thyroid hormone affects gut motility. Hypothyroidism slows gastric emptying and small bowel transit.
Consequence: longer residence time in the small bowel, which favors overgrowth.
Autoimmune thyroid disease involves broader immune activation that affects mucosal immunity and barrier integrity in the small intestine.
Consequence: altered barrier function and immune tone support dysbiosis and recurrent SIBO.
Patients on levothyroxine in the Cedars-Sinai cohort had lower SIBO risk. Better replacement improves motility and metabolic tone.
Consequence: endocrine optimization and SIBO control support each other.
For you, this means hypothyroidism is not a side note in the history. It is part of the SIBO risk profile.
How to factor hypothyroidism into your SIBO workups
You already see bloating, pain, and stool changes all day. The question is when thyroid disease should change your threshold for testing and your follow-up strategy.
Consider SIBO testing or retreatment more strongly when you see
- Documented hypothyroidism or autoimmune thyroid disease plus chronic bloating, pain, or altered stool that predates or outlasts endocrine treatment.
- A history of fluctuating thyroid control with parallel GI symptom swings.
- Partial or short-lived response to prior SIBO therapy in a hypothyroid patient.
- A positive SIBO breath test with no obvious structural or surgical driver, but with known thyroid disease.
When you confirm SIBO in a hypothyroid patient
- Communicate the result to endocrinology.
- Ask whether thyroid control is stable and whether dose adjustments are in progress.
- Flag recurrent SIBO in poorly controlled hypothyroidism as a joint problem to solve.
At-home hydrogen and methane breath testing. Results delivered within 1 business day of sample receipt. Max $299 out-of-pocket.
How to talk about this link with endocrinology
Endocrinologists will care about this connection if you keep the message practical. You can anchor your conversation in three points:
- Hypothyroidism increases SIBO risk through slower motility and immune shifts.
- Treated patients on levothyroxine in the Cedars-Sinai study had lower SIBO risk, which supports the role of good endocrine control.
- Recurrent or severe bloating, pain, or bowel changes in "optimized" hypothyroid patients deserve joint review.
Language you can lift for a referral note or curbside
"This patient has confirmed SIBO and a history of autoimmune hypothyroidism. Transit and immune factors linked to thyroid status likely contribute to the overgrowth picture."
"GI symptoms remain significant despite current thyroid control on labs. A check on dosing, absorption, and stability would help reduce recurrence risk."
"If thyroid status has been unstable, SIBO control will be harder. A shared plan around timing of GI and endocrine adjustments would be useful."
Why a multidisciplinary view helps you
For SIBO, hypothyroidism is one of several non-GI conditions that change pretest probability and recurrence risk. Others include chronic urticaria, asthma and food allergy, systemic sclerosis, and neurologic disease.
If you treat SIBO in isolation
- Higher relapse rates in patients whose underlying motility or immune drivers are not addressed.
- Frustrated patients moving between "GI" and "thyroid" clinics without a joined-up plan.
- More repeat testing and retreatment than necessary.
If you integrate endocrine context
- Clearer risk stratification at the time of ordering breath tests.
- More realistic expectations for patients with autoimmune thyroid disease, especially around recurrence.
- Stronger relationships with referring endocrinologists who see that GI is thinking beyond the lumen.
Key points for your next clinic
When you see your next SIBO or "IBS" patient with thyroid disease, four questions are worth running through:
-
Is the thyroid disease autoimmune, undertreated, or unstable?
Each of those pushes pretest probability up, and the third predicts recurrence.
-
Do GI symptoms line up with thyroid history, or persist despite biochemical control?
Persistence despite normal labs is the pattern most often mislabeled as refractory IBS.
-
Should I test for SIBO now, or watch after better thyroid optimization?
Either can be right. Deciding deliberately beats defaulting.
-
If breath testing is positive, who on the endocrine side adjusts the plan with me?
Name the person before you send the result, not after.
This is the role of Beyond the Gut for GIs. Not to turn you into an endocrinologist, but to ensure your SIBO decisions account for the rest of the patient's story, and to give you simple entry points for multidisciplinary care.
The Beyond the Gut series
Beyond the Gut works through the non-GI conditions that change SIBO pretest probability and recurrence risk, one specialty at a time — endocrinology, rheumatology, dermatology and allergy, pulmonology, neurology, and metabolic disease.
Hypothyroidism and SIBO: FAQs
Does hypothyroidism cause SIBO?
The reported association is one of risk, not established causation. Hypothyroid patients showed higher SIBO risk than euthyroid controls in the Cedars-Sinai cohort, and the mechanisms are plausible: slowed gastric emptying and small bowel transit, plus the immune activation that accompanies autoimmune thyroid disease. Treat thyroid status as a risk factor that raises pretest probability rather than as a diagnosis.
Does levothyroxine treatment reduce SIBO risk?
Patients on levothyroxine in the Cedars-Sinai cohort had lower SIBO risk than untreated hypothyroid patients. That is consistent with better hormone replacement improving motility and metabolic tone, and it supports treating endocrine optimization and SIBO control as complementary rather than sequential.
When should I order a SIBO breath test in a patient with thyroid disease?
Lower your threshold when chronic bloating, pain, or altered stool predates or outlasts endocrine treatment; when thyroid control has fluctuated alongside GI symptom swings; when a prior SIBO course produced only partial or short-lived response; or when a positive breath test has no obvious structural or surgical explanation.
Why does recurrent SIBO keep coming back in my hypothyroid patients?
If the underlying motility or immune driver is not addressed, relapse is likely regardless of how well the overgrowth was cleared. Unstable or undertreated thyroid disease is one of the more common of those drivers. Recurrence in that setting is a signal to loop in endocrinology, not automatically to escalate GI therapy.
Which other non-GI conditions change SIBO pretest probability?
Chronic urticaria, asthma and food allergy, systemic sclerosis, and neurologic disease all appear in this category. Each affects motility, immune tone, or both, which is why the Beyond the Gut series works through them one specialty at a time.
What should I include when I send a SIBO result to endocrinology?
Name the result, the thyroid history, and the specific ask. A workable template: confirmed SIBO plus autoimmune hypothyroidism, transit and immune factors linked to thyroid status likely contributing, and a request to review dosing, absorption, and stability to reduce recurrence risk.
Is at-home breath testing appropriate for these patients?
At-home hydrogen and methane breath testing suits this population well, since the patients most likely to need retesting are also the ones least well served by repeated in-office sessions. CDI's program covers SIBO and IMO plus lactose, fructose, and sucrose malabsorption, with results delivered within 1 business day of sample receipt and a max $299 out-of-pocket cap for patients.
Reference
- Cedars-Sinai Medical Center. Study links hypothyroidism to GI disorder. Findings published in the Journal of Clinical Endocrinology & Metabolism. cedars-sinai.org
Beyond the Gut
Thyroid status belongs in your SIBO workup
When the next hypothyroid patient with unresolved bloating lands on your schedule, breath testing should be simple to order and fast to act on.
